It would also be of value to explore the interaction of PIEZO1 with known renal cancer drivers, such as VHL, HIF-1α, or mTOR, and to assess its impact on angiogenesis, metabolic regulation, and immune cell infiltration. Here, PIEZO1 is linked to renal carcinoma.